35594 Federal Register / Vol. 63, No. 125 /Tuesday, June 30, 1998 / Notices

will be asked to leave your name,

address, and phone number and will

need to refer to NIOSH Announcement

98096. You will receive a complete

program description, information on

application procedures, and application

forms. CDC will not send application

kits by facsimile or express mail. Please

refer to NIOSH announcement number

98096 when requesting information and

submitting an application.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained by

contacting: Victoria Sepe, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Announcement 98096,

Centers for Disease Control and

Prevention (CDC), Room 300, 255 East

Paces Ferry Road, NE., M/S E–13,

Atlanta, GA 30305–2209, telephone

(404) 842–6804, Email address:

vxw1@cdc.gov.

See also the CDC home page on the

Internet: http://www.cdc.gov.

For program technical assistance

contact: Kenneth Mead, P.E., telephone

(513) 841–4319, Email kcm3@cdc.gov,

National Institute for Occupational

Safety and Health, Center for Disease

Control and Prevention (CDC), Division

of Physical Sciences and Engineering,

4676 Columbia Parkway, Mailstop R–5,

Cincinnati, OH 45226.

National Occupational Research

Agenda (NORA): CDC, NIOSH is

committed to the program priorities

developed by NORA. Copies of the

publication, ‘‘The National

Occupational Research Agenda’’ may be

obtained from The National Institute of

Occupational Safety and Health,

Publications Office, 4676 Columbia

Parkway, Cincinnati, OH 45226–1998 or

telephone 1–800–356–4674, and is

available through the NIOSH Home

Page, ‘‘http://www.cdc.gov/niosh/

nora.html’’.

Dated: June 23, 1998.

Diane D. Porter,

Acting Director, National Institute For

Occupational Safety and Health, Centers for

Disease Control and Prevention (CDC).

[FR Doc. 98–17300 Filed 6–29–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Program Announcement Number

98042; Cooperative Agreement for

Waterborne Disease Occurrence

Studies

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1998

funds to provide assistance for

conducting waterborne disease

occurrence studies that will aid in

producing a national estimate of

waterborne disease.

CDC is committed to achieving the

health promotion and disease

prevention objectives of Healthy People

2000, a national activity to reduce

morbidity and mortality and improve

the quality of life. This announcement

is related to the priority area of

Immunization and Infectious Diseases.

(For ordering a copy of Healthy People

2000, see the section WHERE TO OBTAIN

ADDITIONAL INFORMATION.)

Authority

This program is authorized under

Section(s) 301(a), 317(k)(1), and 317

(k)(2) of the Public Health Service Act

[42 U.S.C. 241(a), 247b(k)(1) and

247b(k)(2)], as amended.

Smoke-free Workplace

CDC strongly encourages all grant

recipients to provide a smoke-free

workplace and to promote the nonuse of

all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive Federal funds in which

education, library, day care, health care,

and early childhood development

services are provided to children.

Eligible Applicants

Applications may be submitted by

public and private non-profit entities,

including universities; universityaffiliated systems including not-forprofit medical centers; research

institutions and rehabilitation hospitals;

State and local health departments and

other related State government agencies;

federally recognized Indian tribal

governments, Indian tribes or Indian

tribal organizations, and small,

minority- and/or women-owned nonprofit businesses are eligible to apply.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 which

engages in lobbying activities shall not be

eligible to receive Federal funds constituting

an award, grant, contract, loan, or any other

form.

Availability of Funds

Approximately $450,000 is available

in FY 1998 to fund approximately three

awards. It is expected that the average

award will be $150,000. It is expected

that the awards will begin on or about

September 30, 1998, and will be made

for a 12-month budget period within a

project period of up to two years.

Funding estimates may vary and are

subject to change. Continuation awards

within an approved project period will

be made on the basis of satisfactory

progress and availability of funds.

Use of Funds

Restrictions on Lobbying

Applicants should be aware of

restrictions on the use of Department of

Health and Human Services (HHS)

funds for lobbying of Federal or State

legislative bodies. Under the provisions

of 31 U.S.C. Section 1352 (which has

been in effect since December 23, 1989),

recipients (and their subtier contractors)

are prohibited from using appropriated

Federal funds (other than profits from a

Federal contract) for lobbying Congress

or any Federal agency in connection

with the award of a particular contract,

grant, cooperative agreement, or loan.

This includes grants/cooperative

agreements that, in whole or in part,

involve conferences for which Federal

funds cannot be used directly or

indirectly to encourage participants to

lobby or to instruct participants on how

to lobby.

In addition, the FY 1998 Department

of Labor, Health and Human Services,

and Education, and Related Agencies

Appropriations Act (Public Law 105–78)

states in Section 503 (a) and (b) that no

part of any appropriation contained in

this Act shall be used, other than for

normal and recognized executivelegislative relationships, for publicity or

propaganda purposes, for the

preparation, distribution, or use of any

kit, pamphlet, booklet, publication,

radio, television, or video presentation

designed to support or defeat legislation

pending before the Congress or any

State Legislature, except in presentation

to the Congress or any State legislature

itself. No part of any appropriation

contained in this Act shall be used to

pay the salary or expenses of any grant

or contract recipient, or agent acting for

such recipient, related to any activity

designed to influence legislation or

appropriations pending before the

Congress or any State legislature.
Federal Register / Vol. 63, No. 125 /Tuesday, June 30, 1998 / Notices 35595

Background

The last few years have seen

increased attention to microbiological

contaminants in drinking water. This

concern has led to a number of new

provisions for research and regulation of

such contaminants in the August 1996

Amendments to the Safe Drinking Water

Act (SDWA) P.L. 104–182. Section

137(d) of the 1996 amendments, 42

U.S.C. Section 300j–18d calls for

waterborne disease occurrence studies

to estimate the incidence of waterborne

disease in the United States. Only a

limited number of studies have been

done to develop such an estimate, in

part because some of the methodologies

needed require further refinement and

experience in conducting studies of this

problem is limited. Unfortunately, no

single study or study design will allow

such an estimate to be made with

confidence. The Environmental

Protection Agency (EPA) and CDC are

collaborating to aid other organizations

to conduct studies regarding the

incidence of waterborne disease and

etiologic agents causing waterborne

disease. Such studies will concentrate

on gastrointestinal illness due to

microbial contaminants in drinking

water, including both well known and

emerging bacteria, viruses, and

protozoa. This announcement is not

intended to support studies addressing

illness due to chemical contamination.

Purpose

The purpose of this cooperative

agreement is to provide assistance for

conducting studies to: (1) estimate the

incidence of waterborne disease due to

microbial contamination of drinking

water and/or (2) identify and describe

the relationship between measures of

water quality and health outcomes or

the evidence of infection due to

gastrointestinal pathogens.

Program Requirements

In conducting activities to achieve the

purpose of this program, the recipient

shall be responsible for the activities

under A., below, and CDC shall be

responsible for conducting activities

under B., below:

A. Recipient Activities

1. identify and describe the

population to be studied,

2. identify and describe the water

system(s) serving the population

studied,

3. form a collaborative relationship

with the water utility(s) and local health

department(s) serving the population to

be studied,

4. if appropriate, assess the methods

used by the water utility(s) to measure

water quality and obtain water quality

data. Describe surrogate measures of

water contamination that would be

evaluated,

5. collect data on outcomes of interest

and/or identify and evaluate existing

data on these outcomes. If appropriate,

collect specimens from human

participants to determine the etiologic

agents causing gastrointestinal illness.

Evaluate the likelihood that the etiologic

agents are waterborne,

6. maintain data, including databases,

and confidentiality protections,

7. document your Quality Assurance

Project Plan (QAPP), as required by

EPA, for assuring that the data collected

are of the expected quality for their

intended use and are properly assessed,

8. analyze data to describe the

relationship(s) of the health outcome(s)

with water-related exposure variables,

9. evaluate and describe the

generalizability of the study findings,

and

10. analyze collected data and

disseminate research results by

appropriate methods such as

publication in journals, presentation at

meetings, conferences, etc.

B. CDC Activities

CDC and EPA will provide technical

assistance in the design and conduct of

the research. This may include:

(1) providing technical consultation

in the design and conduct of the project,

including data collection and analytic

approach, and evaluation;

(2) providing technical assistance

regarding special clearances and

approval for human subjects and data

collection;

(3) providing format and guidance for

QAPP

(4) providing educational materials,

including working with grantees to

develop new materials that might be

needed; and

(5) facilitating exchange of

information among recipients.

Technical Reporting Requirements

An original and two copies of an

annual progress report are required and

must be submitted no later than 90 days

after the end of each budget period.

These progress reports must include: (1)

a comparison of actual

accomplishments to the goals and

objectives established for the period;

and (2) the reasons for failure, if

established goals were not met; (3) other

pertinent information including, when

appropriate, analysis and explanation of

performance costs significantly higher

than expected. All manuscripts

published as a result of the work

supported in part or whole by the

cooperative agreement will be submitted

with the progress report.

An annual Financial Status Report

(FSR) must be submitted no later than

90 days after the end of each budget

period.

The final financial status and progress

reports are required no later than 90

days after the end of the project period.

All reports are submitted to Grants

Management Branch, CDC. Please send

all reports or other correspondence to:

Sharron P. Orum, Grants Management

Officer, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, N.E.,

Mailstop E–18, Room 314, Atlanta, GA

30305–2209.

Application Content

Application

An original and five copies of the

application should be submitted to the

Grants Management Officer, Grants

Management Branch, CDC at the address

above. All applicants must develop their

application in accordance with the PHS

Form 398 (revised 5/95), information

contained in this cooperative agreement

announcement, and the instructions

outlined below. In order to ensure an

objective, impartial, and prompt review.

General Instructions

1. All pages must be clearly

numbered.

2. A complete index to the application

and its appendixes must be included.

3. The original and two copies of the

application must be submitted

unstapled and unbound. No bound

material will be accepted.

4. All material must be typewritten,

single spaced, and in unreduced type

(no smaller than font size 12) on 8 1/2’’

by 11’’ white paper, with at least 1’’

margins, headers, and footers.

5. All pages must be printed on one

side only.

Specific Instructions

The application narrative must not

exceed 10 pages (excluding budget and

appendixes). Unless indicated

otherwise, all information requested

below must appear in the narrative.

Materials or information that should be

part of the narrative will not be accepted

if placed in the appendices. The

application narrative must contain the

following sections in the order

presented below:

1. Abstract: Provide a brief (two pages

maximum) abstract of the project.

2. Background and Need: Discuss the

background and need for the proposed

project. Demonstrate a clear
35596 Federal Register / Vol. 63, No. 125 /Tuesday, June 30, 1998 / Notices

understanding of the purpose and

objectives of this cooperative agreement

program. Illustrate and justify the need

for the proposed project that is

consistent with the purpose and

objectives of this cooperative agreement

program.

3. Capacity and Personnel: Describe

applicant’s past experience in

conducting projects/studies similar to

that being proposed. Describe

applicant’s resources, facilities, and

professional personnel that will be

involved in conducting the project.

Include in an appendix curriculum vitae

for all professional personnel involved

with the project. Describe plans for

administration of the project and

identify administrative resources/

personnel that will be assigned to the

project. Provide in an appendix letters

of support from all key participating

non-applicant organizations,

individuals, etc., which clearly indicate

their commitment to participate as

described in the operational plan.

Specifically, letters of support from

water utilities that outline the types of

data they intend to share should be

provided. Do not include letters of

support from CDC or EPA personnel.

Letters of support from CDC or EPA will

not be accepted in the application.

Award of a cooperative agreement

implies CDC and EPA participation as

outlined in the Program Requirements

section of this announcement.

4. Objectives and Technical

Approach: Describe specific objectives

for the proposed project which are

measurable and time-phased and are

consistent with the purpose and goals of

this cooperative agreement. Present a

detailed operational plan for initiating

and conducting the project which

clearly and appropriately addresses all

Recipient Activities. If proposing a two

(2) year project, provide a detailed

description of first-year activities and a

brief overview of activities in the second

year. Clearly state the proposed length

of the project period. Clearly identify

specific assigned responsibilities for all

key professional personnel. Include a

clear description of applicant’s

technical approach/methods which are

directly relevant to the study objectives.

Describe specific study protocols or

plans for the development of study

protocols. Describe the nature and

extent of collaboration with CDC, EPA,

and/or others during various phases of

the project. Describe in detail a plan for

evaluating study results and for

evaluating progress toward achieving

project objectives.

5. Budget: Provide in an appendix a

budget and accompanying detailed

justification for the first-year of the

project that is consistent with the

purpose and objectives of this program.

If proposing a multi-year project, also

provide estimated total budget for each

subsequent year.

6. Human Subjects: Whether or not

exempt from HHS regulations, if the

proposed project involves human

subjects, describe adequate procedures

for the protection of human subjects.

7. Women, Racial, and Ethnic

minorities: Applicants shall ensure that

women, racial and ethnic minority

populations are appropriately

represented in applications for research

involving human subjects. Where clear

and compelling rationale exist that

inclusion is inappropriate or not

feasible, this situation must be

explained as part of the application.

Noncompeting Continuation

Applications

For noncompeting continuation

applications submitted within the

approved project period, include only:

1. brief progress report describing the

accomplishments of the preceding

budget period;

2. New or significantly revised items

or information (objectives, scope of

activities, operational methods,

evaluation), that is not in the initial

application; and

3. Annual budget and justification

(budget items that are unchanged from

the preceding budget period do not need

re-justification, simply list the items in

the budget and note that they are

continuation items).

Evaluation Criteria

The applications will be reviewed and

evaluated according to the following

criteria:

1. Background and Need (10 points):

Extent to which applicant’s

discussion of the background for the

proposed project demonstrates a clear

understanding of the purpose and

objectives of this cooperative agreement

program.

2. Capacity and Personnel (35 points

total):

a. Extent to which applicant describes

adequate resources and facilities (both

technical and administrative) for

conducting the project. (10 points)

b. Extent to which applicant

documents that professional personnel

involved in the project are qualified and

have past experience and achievements

in research related to that proposed as

evidenced by curriculum vitae,

publications, etc. (10 points)

c. Extent to which applicant includes

letters of support from non-applicant

organizations, individuals, etc. Extent to

which the letters clearly indicate the

author’s commitment to participate as

described in the operational plan, such

as a water utility’s intent to provide

specific water quality data. If

appropriate, the extent to which letters

from non-participating local and state

health departments express their

support of the operational plan (15

points). Do not include letters of

support from CDC or EPA personnel.

3. Objectives and Technical Approach

(55 points total):

a. Extent to which applicant describes

specific objectives of the proposed

project which are consistent with the

purpose and goals of this cooperative

agreement program and which are

measurable and time-phased. (10 points)

b. Extent to which applicant presents

a detailed operational plan for initiating

and conducting the project, which

clearly and appropriately addresses all

Recipient Activities. Extent to which

applicant clearly identifies specific

assigned responsibilities for all key

professional personnel. Extent to which

the plan clearly describes applicant’s

technical approach/methods for

conducting the proposed studies and

extent to which the plan is adequate to

accomplish the objectives. Extent to

which applicant describes specific

study protocols or plans for the

development of study protocols that are

appropriate for achieving project

objectives. If there is a laboratory

component to the proposal, the extent to

which plans for ensuring quality of

measurements are included. The extent

the proposed plan includes the

inclusion of women, ethnic, and racial

groups in the proposed research to

include (1) the inclusion of both sexes

and racial and ethnic minority

populations for appropriate

representation, (2) the proposed

justification when representation is

limited or absent, (3) a statement as to

whether the design of the study is

adequate to measure differences when

warranted, and (4) a statement as to

whether the plans for recruitment and

outreach for study participants include

the process of establishing partnerships

with the community and recognition of

mutual benefits will be documented.

If the proposed project involves

human subjects, whether or not exempt

from the HHS regulations, the extent to

which adequate procedures are

described for the protection of human

subjects. Note: Objective Review Group

(ORG) recommendations on the

adequacy of protections include: (1)

protections appear adequate and there

are no comments to make or concerns to

raise, or (2) protections appear adequate,

but there are comments regarding the

protocol, or (3) protections appear
Federal Register / Vol. 63, No. 125 /Tuesday, June 30, 1998 / Notices 35597

inadequate and the ORG has concerns

related to human subjects, or (4)

disapproval of the application is

recommended because the research

risks are sufficiently serious and

protection against the risks are

inadequate as to make the entire

application unacceptable. (25 points)

c. Extent to which applicant describes

adequate and appropriate collaboration

with CDC, EPA and/or others (e.g. water

utilities and health departments) during

various phases of the project. (10 points)

d. Extent to which applicant provides

a detailed and adequate plan for

evaluating study results and for

evaluating progress toward achieving

project objectives. (10 points)

4. Budget (not scored):

Extent to which the proposed budget

is reasonable, clearly justifiable, and

consistent with the intended use of

cooperative agreement funds.

Executive Order 12372 Review

Applications are subject to

Intergovernmental Review of Federal

Programs as governed by Executive

Order 12372 (E.O.), which sets up a

system for State and local government

review of proposed Federal assistance

applications. Applicants (other than

federally recognized Indian tribal

governments) should contact their State

Single Point of Contact (SPOC) as early

as possible to alert them to the

prospective applications and receive

any necessary instructions on the State

process. For proposed projects serving

more than one State, the applicant is

advised to contact the SPOC for each

affected State. A current list of SPOCs

is included in the application kit. Indian

tribes are strongly encouraged to request

tribal government review of the

proposed application. If SPOCs or tribal

governments have any process

recommendations on applications

submitted to CDC, they should forward

them to Sharron Orum, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, N.E., Mailstop E–18,

Room 314, Atlanta, GA 30305–2209.

The due date for State process

recommendations is 30 days after the

application deadline date for new and

competing continuation awards (the

appropriation for this financial

assistance program was received late in

the fiscal year and would not allow for

an application receipt date that would

accommodate the 60-day State

recommendation process period). The

granting agency does not guarantee to

‘‘accommodate or explain’’ for State

process recommendations it receives

after that date.

Public Health System Reporting

Requirements

This program is not subject to the

Public Health System Reporting

Requirements.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance Number is 93.283.

Other Requirements

Paperwork Reduction Act

Projects that involve the collection of

information from ten or more

individuals and funded by the

cooperative agreement will be subject to

review by the Office of Management and

Budget (OMB) under the Paperwork

Reduction Act.

Human Subjects

If the proposed project involves

research on human subjects, the

applicant must comply with the

Department of Health and Human

Services Regulations (45 CFR, Part 46)

regarding the protection of human

subjects. Assurance must be provided to

demonstrate that the project will be

subject to initial and continuing review

by an appropriate institutional review

committee. The applicant will be

responsible for providing evidence of

this assurance in accordance with the

appropriate guidelines and form

provided in the application kit.

Requirements for Inclusion of Women

and Racial and Ethnic Minorities in

Research

It is the policy of the Centers for

Disease Control and Prevention (CDC)

and the Agency for Toxic Substances

and Disease Registry (ATSDR) to ensure

that individuals of both sexes and the

various racial and ethnic groups will be

included in CDC/ATSDR-supported

research projects involving human

subjects, whenever feasible and

appropriate. Racial and ethnic groups

are those defined in OMB Directive No.

15 and include American Indian or

Alaska Native, Asian, Black or African

American, Hispanic or Latino, Native

Hawaiian or Other Pacific Islander.

Applicants shall ensure that women,

racial and ethnic minority populations

are appropriately represented in

applications for research involving

human subjects. Where clear and

compelling rationale exist that inclusion

is inappropriate or not feasible, this

situation must be explained as part of

the application. This policy does not

apply to research studies when the

investigator cannot control the race,

ethnicity and/or sex of subjects. Further

guidance to this policy is contained in

the Federal Register, Vol. 60, No. 179,

pages 47947–47951, and dated Friday,

September 15, 1995.

Application Submission and Deadline

The original and five copies of the

completed application PHS Form 398

(revised 5/95), OMB Control Number

0925–0001) must be submitted to

Sharron P. Orum, Grants Management

Officer, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 314, Mailstop E–18, Atlanta, GA

30305–2209, on or before August 5,

1998.

1. Deadline: Applications shall be

considered as meeting the deadline if

they are either:

a. received on or before the deadline

date; or

b. sent on or before the deadline date

and received in time for submission to

the objective review group. (Applicants

must request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or U.S. Postal Service. Private metered

postmarks shall not be acceptable as

proof of timely mailing.)

2. Late Applications: Applications

which do not meet the criteria in 1. a.

or 1. b. above are considered late

applications. Late applications will not

be considered in the current

competition and will be returned to the

applicant.

Where to Obtain Additional

Information

To receive additional written

information and to request an

application kit, call 1–888-GRANTS4

(1–888–472–6874). You will be asked to

leave your name and address and will

be instructed to identify the

Announcement number of interest. If

you have any questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from Gladys

T. Gissentanna, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 314, Mailstop E–18, Atlanta, GA

30305–2209, (404) 842–6801. E-mail

address: gcg4@cdc.gov.

Programmatic technical assistance

may be obtained from Bill MacKenzie,

MD, Division of Parasitic Diseases,

National Center for Infectious Diseases,

Centers for Disease Control and

Prevention (CDC), 1600 Clifton Road,
35598 Federal Register / Vol. 63, No. 125 /Tuesday, June 30, 1998 / Notices

NE., Atlanta, GA 30333, Telephone:

(770) 488–7784. E-mail address:

wrm0@cdc.gov

Please refer to Announcement

Number 98042 when requesting

information regarding this program.

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report, Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report,

Stock No. 017–001–00473–1) referenced

in the Introduction through the

Superintendent of Documents,

Government Printing Office,

Washington, DC 20402-9325,

telephone:(202) 512–1800.

Dated: June 24, 1998.

John L. Williams,

Director Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 98–17306 Filed 6–29–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

[Program Announcement No. ACF/ACYF/

CB–98–04A]

Announcement of the Availability of

Financial Assistance and Request for

Applications to Support Demonstration

Projects Under the Adoption

Opportunities Program

AGENCY: Administration on Children,

Youth and Families (ACYF), ACF,

DHHS.

ACTION: Notice of correction.

SUMMARY: This notice corrects the

Notice of an Announcement published

in the Federal Register on June 9, 1998

(63 FR 31502) by correcting the category

of eligible applicants under Priority

Area 98.3—Achieving Increased

Placements of Children in Foster Care.

For this priority area only State agencies

are eligible to compete for funds. Under

section 203(d)(1) of Title II of the Child

Abuse Prevention and Treatment Act, as

amended, Pub. L. 104–235, states that

the Secretary ‘‘shall make grants for

improving State efforts to increase the

placement of foster children legally free

for adoption * * *. Additionally, states

are encouraged to collaborate with

private, non-profit agencies and Indian

tribes to increase the number of

adoptions or permanent placements of

children who are in foster care.

FOR FURTHER INFORMATION CONTACT:

Administration on Children, Youth and

Families (ACYF) Operations Center,

1225 Jefferson Davis Highway, Suite

415, Arlington, Virginia 22201, the

telephone number is 1–800–351–2293.

SUPPLEMENTARY INFORMATION: On June 9,

1998, the Administration on Children,

Youth and Families published the

Notice of Announcement Number: CB–

98–04 in the Federal Register soliciting

proposals to support demonstration

projects under the Adoption

Opportunities Program. The eligibility

should have been limited to State social

service agencies. This amendment

corrects that error. Further, the

Children’s Bureau encourages states to

develop collaborate agreements with

private, non-profit agencies and Indian

tribes to increase the number of

adoptions or permanent placements of

children who are in foster care. All

other requirements for mailed

applications/overnight/express mail

service and hand-delivered

applications/applicant couriers remain

the same as in the original

announcement.

(Catalog of Federal Domestic Assistance

Program Number 93.652, Adoption

Opportunities Program)

Dated: June 23, 1998.

James A. Harrell,

Deputy Commissioner, Administration on

Children, Youth and Families.

[FR Doc. 98–17313 Filed 6–29–98; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

[Program Announcement No. OCSE 98TIP–

1]

Child Support Enforcement

Demonstration and Special Projects;

Federal/Tribal Grant (Cooperative

Agreement) to Plan Tribal Child

Support Programs

AGENCY: Office of Child Support

Enforcement, ACF, DHHS.

ACTION: Notice.

SUMMARY: The OCSE invites eligible

entities to submit competitive grant

applications to assist them in planning

and preparing to run their own child

support program. Applications will be

screened and evaluated as indicated in

this program announcement. Awards

will be contingent on the outcome of the

competition and the availability of

funds.

DATES: The closing date for submission

of applications is August 31, 1998. See

Part IV of this announcement for more

information on submitting applications.

ADDRESSES: Application kits containing

the necessary forms and instructions to

apply for a grant under this program

announcement are available from:

Administration for Children and

Families, Office of Child Support

Enforcement, Office of Automation and

Special Projects (OCSE/OASP), 370

L’Enfant Promenade, SW, 4th Floor,

West Wing, Washington, DC 20447,

Attention: Jay Adams, (202) 401–9240,

401–5539 (FAX),

ljadams@ACF.DHHS.GOV,

www.acf.dhhs.gov/programs/oa/

form.htm.

FOR FURTHER INFORMATION CONTACT:

Administration for Children and

Families (ACF), OCSE/OASP, Lucille

Dawson at (202) 401–5437 or Lawrence

A. Dunmore, III at (202) 205–4554, for

specific program concerns regarding the

announcement. Lois Hodge, Grants

Officer/Team 1, (202) 401–2344.

SUPPLEMENTARY INFORMATION: This

program announcement consists of four

parts:

Part I: Background—program purpose,

program objectives, legislative authority,

funding availability, and Catalog of

Federal Domestic Assistance (CFDA)

Number.

Part II: Applicant and Project

Eligibility—eligible applicants,

priorities and preferences, and project

and budget periods.

Part III: The Review Process—

intergovernmental review, initial ACF

screening, competitive review and

evaluation criteria, funding

reconsideration.

Part IV: The Application—application

development, application submission.

Paperwork Reduction Act of 1995

(Pub. L. 104–13): Public reporting

burden for this collection of information

is estimated to average 20 hours per

response, including the time for

reviewing instructions, gathering and

maintaining the data needed, and

reviewing the collection of information.

The following information collections

within this Program Announcement are

approved under the following currently

valid OMB control numbers: 424 (0348–

0043); 424A (0348–0044); 424B (0348–

0040); Disclosure of Lobbying Activities

(0348–0046); Uniform Project

Description (0970–0139 Expiration date

10/31/00).

An agency may not conduct or

sponsor, and a person is not required to

respond to, a collection of information

unless it displays a currently valid OMB

control number.